Agenda

Thursday, October 16 All times in Eastern Time
7:00 AM	Registration/Continental Breakfast/Exhibits
7:55 AM	Welcome and Announcements Lars G. Svensson, MD, PhD
	Session I - Prevention and Management of CV Risk Part 1 Moderator: Amy Zack, MD
8:00 AM	Lipoprotein(a): New Frontiers in Risk Reduction Ashish Sarraju, MD
8:15 AM	Statin Initiation for Primary Prevention Among Statin Naïve Adults and How Can We Mitigate Nonadherence Vikas Sunder, MD
8:30 AM	When Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk Abhayjit Singh, MD
8:45 AM	Who Should Get a CAC? How Often? How to Use the Results to Assess Risk? Gary Parizher, MD
9:00 AM	Optimizing Cardiovascular Disease Risk in Overweight and Obesity: Diet, Drugs and Surgery Ashish Sarraju, MD
9:15 AM	Genetics and Genomics Joseph Liu, MS, CGC
9:30 AM	Functional Medicine Approach to Preventing CV Disease James Carter, MD
9:45 AM	Key Aspects of Population Health Management in CVD Amy Zack, MD
10:00 AM	Panel Discussion and Q&A Session Faculty
10:15 AM	Break
	Session II: Prevention and Management of Risk Part 2 Moderator: Luke Laffin, MD
10:35 AM	Can Hormone Therapy Improve Heart and Metabolic Health? Embracing the Evidence Holly Thacker, MD
10:50 AM	Emerging Evidence in Hypertension Management and Strategies for Resistant HTN Luke Laffin, MD
11:05 AM	Treating Cardiovascular Disease and Diabetes: Clinical Trials to Patient Care Dennis Bruemmer, MD, PhD
11:20 AM	Management of CV Issues in the Elderly: Geriatric Cardiology Abdulla Damluji, MD, PhD, MBA
11:35 AM	Cardiac Disease Remains the Leading Cause of Mortality in Women: What are we Doing to Address This? Leslie Cho, MD
11:50 AM	Social Determinants of Cardiovascular Health: Key Drivers of Cardiovascular Risk Anthony Fletcher, MD
12:05 PM	Panel Discussion and Q&A Session Faculty
12:20 PM	Lunch
	Session III: Special Populations Moderator: Tamanna Singh, MD
1:20 PM	Cardiovascular Disease and Pregnancy: Optimizing Maternal and Fetal Health Karlee Hoffman, DO
1:35 PM	Competitive Sports Participation in Athletes with Heart Disease: Evaluation and Management Tamanna Singh, MD
1:50 PM	Cardio-Oncology: Cardio-Protection and Prediction of Cardiotoxicity Rohit Moudgil, MD
2:05 PM	Panel Discussion and Q&A Session Faculty
2:20 PM	Refreshment Break/Exhibits
	Session IV: Essentials of CVD Moderator: Venu Menon, MD
2:35 PM	Role of Advanced Imaging for Ischemic Heart Disease: CT, CMR, Nuclear and Advanced Echocardiography Saberio Lo Presti Vega, MD
2:50 PM	Chronic Coronary Disease Management in 2025: What’s New in the Guidelines? Laura Young, MD
3:05 PM	ANOCA, INOCA, MINOCA: What Does It All Mean? Diagnostic Testing and Therapeutic Management Khaled Ziada, MD
3:20 PM	Daily Dilemmas in the Management of Stable Ischemic Heart Disease Ben Alencherry, MD
3:35 PM	DAPT or SAPT Following an Acute Coronary Syndrome? Venu Menon, MD
3:50 PM	Peripheral Artery Disease: Assessment and Clinical Decision Making Lee Kirksey, MD
4:05 PM	Panel Discussion and Q&A Session Faculty
4:25 PM	Adjourn Day 1

Friday, October 17 All times in Eastern Time
7:00 AM	Continental Breakfast/Exhibits
8:00 AM	Welcome and Announcements Lee Kirksey, MD
	Session V: Structural Heart Disease Moderator: Samir Kapadia, MD
8:10 AM	Contemporary Trends in Aortic Valve Disease Management: Guidelines and Implications of Clinical Trials Leonardo Rodriguez, MD
8:25 AM	Evaluation of Surgical and Interventional Therapies in Aortic Valve Disease: Key Points for Shared Decision Making Samir Kapadia, MD
8:40 AM	Guideline Directed Evaluation and Management of Mitral Valve Disease: When, Why and How to Diagnosis Bryan Abadie, MD
8:55 AM	Current Status of Transcatheter Mitral and Tricuspid Valve Therapies: Repair and Replace Amar Krishnaswamy, MD
9:10 AM	Guidelines for Anticoagulation Following Structural Heart Therapies Grant Reed, MD
9:25 AM	Bicuspid and Aneurysm-Associated Aortic Valve Disease: Timing of Intervention and the Role of Family History Vidyasagar Kalahasti, MD
9:40 AM	Panel Discussion and Q&A Session Faculty
10:00 AM	Break
	Session VI: Heart Rhythm Moderator: Mohamed Kanj, MD
10:20 AM	Assessment and Management of Stroke Risk in New-Onset Atrial Fibrillation Kevin F. Kwaku, MD, PhD
10:35 AM	Lifestyle Modifications in AF Management: What Are the Most Important Priorities for My Patients Mohamed Kanj, MD
10:50 AM	Evaluation and Management of Patients with Frequent PVCs and SVTs Pasquale Santangeli, MD, PhD
11:05 AM	LAA Closure: Who to Refer and Management After Implantation Walid Saliba, MD
11:20 AM	Evaluation and Management of Syncope: Syncope Guidelines in Action Kenneth Mayuga, MD
11:35 AM	Wearables for Arrhythmia Care: Current Science and Future Prospects Niraj Varma, MD, PhD
11:50 AM	Panel Discussion and Q&A Session Faculty
12:05 PM	Lunch
	Session VII: Heart Failure Moderator: Pavan Bhat, MD
1:05 PM	How to Screen for HF in the Primary Care Setting: Earlier Diagnosis and Treatment Randall Starling, MD, MPH
1:20 PM	HFrEF: Initiation and Optimization of GDMT in the Ambulatory and Inpatient Care Setting Pavan Bhat, MD
1:35 PM	Preoperative Optimization and Management of Heart Failure Patients Maria Mountis, DO
1:50 PM	Managing Co-Morbidity in HF: The Cardio-Kidney-Metabolic Disease (CKM) Paradigm M. Trejeeve Martyn, MD
2:05 PM	Insights in Heart Failure with Preserved Ejection Fraction: Current and Emerging Therapies Sanjeeb Bhattacharya, MD
2:20 PM	Obesity and Heart Failure: Evolving Therapies Sanjeeb Bhattacharya, MD
2:35 PM	Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) J. Emanuel Finet, MD
2:50 PM	Contemporary Approaches to Medical Therapy for HCM Milind Desai, MD, MBA
3:05 PM	Is This Advanced Heart Failure? When to Refer for LVAD/Transplant Michael Tong, MD
3:20 PM	Population Outcomes Across the Spectrum of Heart Failure Tuoyo Mene-Afejuku, MD
3:35 PM	Panel Discussion and Q&A Session Faculty
3:50 PM	Adjourn

Agenda

Thursday, October 16
All times in Eastern Time

Session I - Prevention and Management of CV Risk Part 1
Moderator: Amy Zack, MD

Session II: Prevention and Management of Risk Part 2
Moderator: Luke Laffin, MD

Session III: Special Populations
Moderator: Tamanna Singh, MD

Session IV: Essentials of CVD
Moderator: Venu Menon, MD

Friday, October 17
All times in Eastern Time

Session V: Structural Heart Disease
Moderator: Samir Kapadia, MD

Session VI: Heart Rhythm
Moderator: Mohamed Kanj, MD

Session VII: Heart Failure
Moderator: Pavan Bhat, MD

Agenda

Thursday, October 16 All times in Eastern Time

Session I - Prevention and Management of CV Risk Part 1 Moderator: Amy Zack, MD

Session II: Prevention and Management of Risk Part 2 Moderator: Luke Laffin, MD

Session III: Special Populations Moderator: Tamanna Singh, MD

Session IV: Essentials of CVD Moderator: Venu Menon, MD

Friday, October 17 All times in Eastern Time

Session V: Structural Heart Disease Moderator: Samir Kapadia, MD

Session VI: Heart Rhythm Moderator: Mohamed Kanj, MD

Session VII: Heart Failure Moderator: Pavan Bhat, MD

Thursday, October 16
All times in Eastern Time

Session I - Prevention and Management of CV Risk Part 1
Moderator: Amy Zack, MD

Session II: Prevention and Management of Risk Part 2
Moderator: Luke Laffin, MD

Session III: Special Populations
Moderator: Tamanna Singh, MD

Session IV: Essentials of CVD
Moderator: Venu Menon, MD

Friday, October 17
All times in Eastern Time

Session V: Structural Heart Disease
Moderator: Samir Kapadia, MD

Session VI: Heart Rhythm
Moderator: Mohamed Kanj, MD

Session VII: Heart Failure
Moderator: Pavan Bhat, MD